The Claim
In critically ill patients with COVID-19, intravenous vitamin C administered at 1.5 grams every 6 hours for up to 4 days is not significantly associated with reduced vasopressor requirements or reduced ICU length of stay compared to matched controls.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In critically ill patients with COVID-19, receiving intravenous vitamin C at 1.5 grams every 6 hours for up to 4 days does not result in lower use of vasopressor drugs or shorter stays in the intensive care unit compared to similar patients who did not receive this treatment.
See the scientific wording
In critically ill patients with COVID-19, intravenous vitamin C at 1.5 grams every 6 hours for up to 4 days shows no significant association with reduced vasopressor requirements or ICU length of stay compared to matched controls.
Vitamin C does not change how blood vessels control pressure or how the lining of blood vessels responds to severe illness, so blood pressure medicines are still needed and recovery in the ICU takes the same amount of time.
What the research says
1 studyStudy: Use of Intravenous Vitamin C in Critically Ill Patients With COVID-19 Infection
In very sick COVID-19 patients, giving high-dose IV vitamin C didn’t make them need less blood pressure medicine or leave the ICU sooner than patients who didn’t get it — which is exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.